BYROW replaces thousands of table formulas with one spill formula, making spreadsheets leaner and much more robust.
Natalizumab (originator and biosimilar) for treating highly active relapsing–remitting multiple sclerosis after disease-modifying therapy TA1126 28 January 2026 28 January 2026 Concizumab for treating ...